Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases

Autophagy is an intracellular degradation pathway for malfunctioning aggregation-prone proteins, damaged organelles, unwanted macromolecules and invading pathogens. This process is essential for maintaining cellular and tissue homeostasis that contribute to organismal survival. Autophagy dysfunction...

Full description

Bibliographic Details
Main Authors: Prashanta Kumar Panda, Alexandra Fahrner, Somya Vats, Elena Seranova, Vartika Sharma, Miruna Chipara, Priyal Desai, Jorge Torresi, Tatiana Rosenstock, Dhiraj Kumar, Sovan Sarkar
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2019.00038/full
_version_ 1818060719032107008
author Prashanta Kumar Panda
Alexandra Fahrner
Somya Vats
Somya Vats
Elena Seranova
Vartika Sharma
Miruna Chipara
Priyal Desai
Jorge Torresi
Jorge Torresi
Tatiana Rosenstock
Tatiana Rosenstock
Dhiraj Kumar
Sovan Sarkar
author_facet Prashanta Kumar Panda
Alexandra Fahrner
Somya Vats
Somya Vats
Elena Seranova
Vartika Sharma
Miruna Chipara
Priyal Desai
Jorge Torresi
Jorge Torresi
Tatiana Rosenstock
Tatiana Rosenstock
Dhiraj Kumar
Sovan Sarkar
author_sort Prashanta Kumar Panda
collection DOAJ
description Autophagy is an intracellular degradation pathway for malfunctioning aggregation-prone proteins, damaged organelles, unwanted macromolecules and invading pathogens. This process is essential for maintaining cellular and tissue homeostasis that contribute to organismal survival. Autophagy dysfunction has been implicated in the pathogenesis of diverse human diseases, and therefore, therapeutic exploitation of autophagy is of potential biomedical relevance. A number of chemical screening approaches have been established for the drug discovery of autophagy modulators based on the perturbations of autophagy reporters or the clearance of autophagy substrates. These readouts can be detected by fluorescence and high-content microscopy, flow cytometry, microplate reader and immunoblotting, and the assays have evolved to enable high-throughput screening and measurement of autophagic flux. Several pharmacological modulators of autophagy have been identified that act either via the classical mechanistic target of rapamycin (mTOR) pathway or independently of mTOR. Many of these autophagy modulators have been demonstrated to exert beneficial effects in transgenic models of neurodegenerative disorders, cancer, infectious diseases, liver diseases, myopathies as well as in lifespan extension. This review describes the commonly used chemical screening approaches in mammalian cells and the key autophagy modulators identified through these methods, and highlights the therapeutic benefits of these compounds in specific disease contexts.
first_indexed 2024-12-10T13:36:53Z
format Article
id doaj.art-2fa86eda4901481e8895cb69bf3d562b
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-10T13:36:53Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-2fa86eda4901481e8895cb69bf3d562b2022-12-22T01:46:47ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2019-03-01710.3389/fcell.2019.00038442492Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human DiseasesPrashanta Kumar Panda0Alexandra Fahrner1Somya Vats2Somya Vats3Elena Seranova4Vartika Sharma5Miruna Chipara6Priyal Desai7Jorge Torresi8Jorge Torresi9Tatiana Rosenstock10Tatiana Rosenstock11Dhiraj Kumar12Sovan Sarkar13Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomMolecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru, IndiaInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomCellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, IndiaInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomDepartment of Physiological Science, Santa Casa de São Paulo School of Medical Sciences, São Paulo, BrazilInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomDepartment of Physiological Science, Santa Casa de São Paulo School of Medical Sciences, São Paulo, BrazilCellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, IndiaInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United KingdomAutophagy is an intracellular degradation pathway for malfunctioning aggregation-prone proteins, damaged organelles, unwanted macromolecules and invading pathogens. This process is essential for maintaining cellular and tissue homeostasis that contribute to organismal survival. Autophagy dysfunction has been implicated in the pathogenesis of diverse human diseases, and therefore, therapeutic exploitation of autophagy is of potential biomedical relevance. A number of chemical screening approaches have been established for the drug discovery of autophagy modulators based on the perturbations of autophagy reporters or the clearance of autophagy substrates. These readouts can be detected by fluorescence and high-content microscopy, flow cytometry, microplate reader and immunoblotting, and the assays have evolved to enable high-throughput screening and measurement of autophagic flux. Several pharmacological modulators of autophagy have been identified that act either via the classical mechanistic target of rapamycin (mTOR) pathway or independently of mTOR. Many of these autophagy modulators have been demonstrated to exert beneficial effects in transgenic models of neurodegenerative disorders, cancer, infectious diseases, liver diseases, myopathies as well as in lifespan extension. This review describes the commonly used chemical screening approaches in mammalian cells and the key autophagy modulators identified through these methods, and highlights the therapeutic benefits of these compounds in specific disease contexts.https://www.frontiersin.org/article/10.3389/fcell.2019.00038/fullautophagyautophagy reporterautophagy substrateautophagy modulatorscreening methodneurodegenerative diseases
spellingShingle Prashanta Kumar Panda
Alexandra Fahrner
Somya Vats
Somya Vats
Elena Seranova
Vartika Sharma
Miruna Chipara
Priyal Desai
Jorge Torresi
Jorge Torresi
Tatiana Rosenstock
Tatiana Rosenstock
Dhiraj Kumar
Sovan Sarkar
Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
Frontiers in Cell and Developmental Biology
autophagy
autophagy reporter
autophagy substrate
autophagy modulator
screening method
neurodegenerative diseases
title Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
title_full Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
title_fullStr Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
title_full_unstemmed Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
title_short Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
title_sort chemical screening approaches enabling drug discovery of autophagy modulators for biomedical applications in human diseases
topic autophagy
autophagy reporter
autophagy substrate
autophagy modulator
screening method
neurodegenerative diseases
url https://www.frontiersin.org/article/10.3389/fcell.2019.00038/full
work_keys_str_mv AT prashantakumarpanda chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT alexandrafahrner chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT somyavats chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT somyavats chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT elenaseranova chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT vartikasharma chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT mirunachipara chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT priyaldesai chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT jorgetorresi chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT jorgetorresi chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT tatianarosenstock chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT tatianarosenstock chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT dhirajkumar chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases
AT sovansarkar chemicalscreeningapproachesenablingdrugdiscoveryofautophagymodulatorsforbiomedicalapplicationsinhumandiseases